Search research articles
Contact Us
Filters
Showing results (1141-1150 of 1,281) with videos related to
Page
of 129
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 30, 2019
Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus
Nicolas Salvadori, Bo Fan, Waralee Teeyasoontranon, et al.
JTO Clinical and Research Reports
|
June 9, 2025
Health Utility and Symptom Scores in Patients With Advanced Malignant Pleural Mesothelioma Treated in a Real-World Setting
Abhenil Mittal, Louis Everest, Devalben Patel, et al.
European Urology Oncology
|
November 14, 2021
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer
Estefania Labanca, Jun Yang, Peter D A Shepherd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study
Glenwood D Goss, Chris O'Callaghan, Ian Lorimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2015
Integrating RAS status into prognostic signatures for adenocarcinomas of the lung
Maud H W Starmans, Melania Pintilie, Michelle Chan-Seng-Yue, et al.
Cancer Epidemiology
|
January 28, 2016
ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients
Sinead Cuffe, Abul Kalam Azad, Xiaoping Qiu, et al.
Scientific Reports
|
April 15, 2024
Non-invasive biomarkers for detecting progression toward hypovolemic cardiovascular instability in a lower body negative pressure model
Ethan K Murphy, Spencer R Bertsch, Samuel B Klein, et al.
Oncogene
|
September 29, 2021
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel
Estefania Labanca, Juan Bizzotto, Pablo Sanchis, et al.
Journal of the National Cancer Institute
|
July 31, 2014
Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25
Patrick Cheung, Sergio Faria, Shahida Ahmed, et al.
The New England Journal of Medicine
|
December 14, 2016
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
Tony S Mok, Yi-Long Wu, Myung-Ju Ahn, et al.
Page
of 129
Search research articles
Search
Showing results (1141-1150 of 1,281) with videos related to
Sort By:
Page
of 129
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 30, 2019
Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus
Nicolas Salvadori, Bo Fan, Waralee Teeyasoontranon, et al.
JTO Clinical and Research Reports
|
June 9, 2025
Health Utility and Symptom Scores in Patients With Advanced Malignant Pleural Mesothelioma Treated in a Real-World Setting
Abhenil Mittal, Louis Everest, Devalben Patel, et al.
European Urology Oncology
|
November 14, 2021
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer
Estefania Labanca, Jun Yang, Peter D A Shepherd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study
Glenwood D Goss, Chris O'Callaghan, Ian Lorimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2015
Integrating RAS status into prognostic signatures for adenocarcinomas of the lung
Maud H W Starmans, Melania Pintilie, Michelle Chan-Seng-Yue, et al.
Cancer Epidemiology
|
January 28, 2016
ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients
Sinead Cuffe, Abul Kalam Azad, Xiaoping Qiu, et al.
Scientific Reports
|
April 15, 2024
Non-invasive biomarkers for detecting progression toward hypovolemic cardiovascular instability in a lower body negative pressure model
Ethan K Murphy, Spencer R Bertsch, Samuel B Klein, et al.
Oncogene
|
September 29, 2021
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel
Estefania Labanca, Juan Bizzotto, Pablo Sanchis, et al.
Journal of the National Cancer Institute
|
July 31, 2014
Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25
Patrick Cheung, Sergio Faria, Shahida Ahmed, et al.
The New England Journal of Medicine
|
December 14, 2016
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
Tony S Mok, Yi-Long Wu, Myung-Ju Ahn, et al.
Page
of 129